The Effect of Sexual Health Training Given to Nursing Students on Knowledge and Attitude

December 7, 2023 updated by: CEYDA SU GUNDUZ, Marmara University

The Effect of Sexual Health Training Given to Nursing Students With the PLISSIT Model on Knowledge and Attitude

Nurses play an important role in providing sexual health care to individuals. In this study, sexual health education will be implemented in an innovative way by supporting the use of models in the process of sexual counseling of nursing students to patients. The PLISSIT model, which is most frequently used when providing sexual counseling services to patients, will be taught to nursing students and its effectiveness will be determined. In the literature, only one study was found regarding the use of the PLISSIT model in sexual health assessment, conducted with students. The research was planned as pretest-posttest comparative, randomised, with an experimental and a control group, and with repeated measurements, in order to determine the effect of sexual health education given to nursing students with the PLISSIT model on sexual health care knowledge, sexual health care attitudes and myths about sexual health. This research will be carried out between December 2023 and March 2024 with the participation of fourth-year students studying at Marmara University, Faculty of Health Sciences, Department of Nursing. Students who meet the inclusion criteria will be randomly assigned to experimental (n=45) and control (n=45) groups. The data of the research will be obtained using the "Student Information Form", "Knowledge of Sexual Healthcare Scale ", "Attitude to Sexual Healthcare Scale", "Sexual Myths Scale" and "Student Opinion Form on Sexual Health Education". Ethical permission and institutional permission were obtained. The research While routine training will be given to the control group during the training, the experimental group will be given sexual health training including 16 hours of PLISSIT model teaching by the researcher. The data of the research will be obtained before the training, immediately after the training and 3 months after the training, using a data collection form.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Sexuality is a central aspect of being human that encompasses all life. Nurses play an important role in providing sexual health care to individuals. There is evidence in the literature that the knowledge and skills that nurses should have in order to provide sexual health care are not sufficient. The main reason why nurses have problems in the provide sexual health care is that the subject of sexuality is not sufficiently included in the undergraduate nursing education. Sexual health education programs should be structured in a way to effectively increase the competencies of nursing students. The use of models in sexual counseling enables students to relate theory and practice to sexual health care. In this study, sexual health training will be implemented in an innovative way by supporting the use of models in the process of providing sexual counseling to the patients of nursing students. The most commonly used PLISSIT model will be taught to nursing students while providing sexual counseling to patients and its effectiveness will be determined. In the literature, only one study was found with students on the use of the PLISSIT model in sexual health assessment. The research is planned to be pre-test post-test comparative, randomized, with one experiment and one control group, repeated measurement ın order to determine the effect of the sexual health training given to nursing students with the PLISSIT model on the myths about sexuality, sexual health care knowledge and sexual health care attitude. This research will be carried out between December 2023 and March 2024 with the participation of fourth grade students studying at Marmara University Faculty of Health Sciences, Department of Nursing. Students who is suitable the inclusion criteria will be randomized to the experimental (n=45) and control groups (n=45). The data of the research will be obtained by using "Student Information Form", "Sexual Health Care Knowledge Scale", "Sexual Health Care Attitude Scale" and "Sexual Myths Scale" and "Student Opinion Form on Sexual Health Education". Ethical permission and institutional permission were obtained.During the research, while the control group receives routine training, the experimental group will be given a sexual health assessment training including 16 hours of PLISSIT model teaching by the researcher. The data of the research will be obtained by using the data collection form before the training, immediately after the training and 3 months after the training. By ensuring that nursing students learn and practice sexual health assessment, the sexual health of individuals will be protected and improved.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
90

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey
      • Istanbul, Turkey, 34854
        • Marmara University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a senior nursing student,
  • Having sufficient Turkish speaking and understanding skills,
  • Agreeing to participate in sexuality education on the online platform if necessary,
  • Sufficient or unlimited internet access,
  • Having any computer, tablet or smart phone,
  • Being willing to participate in the research

Exclusion Criteria:

  • Desire to leave the research,
  • Incomplete filling of data collection forms,
  • Not attending more than 30% of the training given in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: Control group
Nursing students in this group will not be subjected to any application and will continue their routine nursing lessons. The questionnaire will be administered to the control group before the training given to the experimental group, immediately after the training and 3 months after the training.
Experimental: PLISSIT Group
Nursing students in this group will be given sexual health training. The training will last for 4 weeks. The training is 16 hours in total. During the training, students will learn the PLISSIT model and evaluate cases involving using this model. Questionnaire will be applied before the training, immediately after the training and 3 months after the training.
Behavioral: sexual health training
The 16-hour sexual health training will be given for 4 weeks. Case discussions using the PLISSIT Model will be held in the training content.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Knowledge of Sexual Healthcare Scale
Time Frame: baseline
The scale was designed to measure the knowledge of nursing students about sexual health care. The scale consists of 31 items. Each item was rated as "yes", "no" and "I don't know". 1 point is given for the correct answer, 0 points for the wrong answer and the answer I don't know. A score between 0-31 can be obtained from the scale.
baseline
Knowledge of Sexual Healthcare Scale
Time Frame: month 3
The scale was designed to measure the knowledge of nursing students about sexual health care. The scale consists of 31 items. Each item was rated as "yes", "no" and "I don't know". 1 point is given for the correct answer, 0 points for the wrong answer and the answer I don't know. A score between 0-31 can be obtained from the scale.
month 3
Attitude to Sexual Healthcare Scale
Time Frame: baseline
The scale determines the attitudes of nursing students towards sexual health services. The scale consists of 3 sub-dimensions and a total of 18 questions. Each item on the 5-point Likert scale is rated as 5 = strongly agree, 4 = agree, 3 = undecided, 2 = disagree, and 1 = strongly disagree. The scores that can be obtained from the scale vary between 18 and 90.
baseline
Attitude to Sexual Healthcare Scale
Time Frame: month 3
The scale determines the attitudes of nursing students towards sexual health services. The scale consists of 3 sub-dimensions and a total of 18 questions. Each item on the 5-point Likert scale is rated as 5 = strongly agree, 4 = agree, 3 = undecided, 2 = disagree, and 1 = strongly disagree. The scores that can be obtained from the scale vary between 18 and 90.
month 3
Knowledge of Sexual Healthcare Scale
Time Frame: week 4
The scale was designed to measure the knowledge of nursing students about sexual health care. The scale consists of 31 items. Each item was rated as "yes", "no" and "I don't know". 1 point is given for the correct answer, 0 points for the wrong answer and the answer I don't know. A score between 0-31 can be obtained from the scale.
week 4
Attitude to Sexual Healthcare Scale
Time Frame: week 4
The scale determines the attitudes of nursing students towards sexual health services. The scale consists of 3 sub-dimensions and a total of 18 questions. Each item on the 5-point Likert scale is rated as 5 = strongly agree, 4 = agree, 3 = undecided, 2 = disagree, and 1 = strongly disagree. The scores that can be obtained from the scale vary between 18 and 90.
week 4

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Sexual Myths Scale
Time Frame: baseline
The scale has been reported to be a useful tool to reveal whether a person's knowledge is based on sexual myths. In this 5-point Likert-type scale, consisting of 28 items, statements are evaluated between "1" points (I never agree), "5" points (I totally agree). The scale consists of 8 sub-dimensions and 28 items. The total score that can be obtained from the scale can vary between 28-140.
baseline
Sexual Myths Scale
Time Frame: month 3
The scale has been reported to be a useful tool to reveal whether a person's knowledge is based on sexual myths. In this 5-point Likert-type scale, consisting of 28 items, statements are evaluated between "1" points (I never agree), "5" points (I totally agree). The scale consists of 8 sub-dimensions and 28 items. The total score that can be obtained from the scale can vary between 28-140.
month 3
Sexual Myths Scale
Time Frame: week 4
The scale has been reported to be a useful tool to reveal whether a person's knowledge is based on sexual myths. In this 5-point Likert-type scale, consisting of 28 items, statements are evaluated between "1" points (I never agree), "5" points (I totally agree). The scale consists of 8 sub-dimensions and 28 items. The total score that can be obtained from the scale can vary between 28-140.
week 4
Student Opinion Form on Sexual Health Education (part 1)
Time Frame: week 4
It determines the thoughts of the students about the model taught in education and the satisfaction of the students from the education.
week 4
Student Opinion Form on Sexual Health Education (part 2)
Time Frame: month 3
It determines the impact of education on providing sexual health care to individuals during intern internship of students.
month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Marmara University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Nurdan Demirci, Prof., Marmara University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
December 1, 2023

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 1, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 1, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 7, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 31, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 1, 2023

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 14, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 7, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • marmaraceydasugunduzistanbul34

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings